FDA-Cleared, AI-Powered Sleep Diagnosis Using Pulse Oximeters
Accelerate the identification, diagnosis, and treatment of sleep disordered breathing with accurate, affordable, AI-driven analysis of photoplethysmogram (PPG) signals captured by pulse oximeters using EnsoSleep PPG™, by measuring respiratory activity based on changes in blood volume and peripheral arterial tone.
Expand Patient Access and Advance Home Sleep Testing
Enhance Sleep Disorder Diagnosis and Patient Monitoring
Access, review, and edit all AI-scored HSAT, PSG, and PPG-based sleep studies in Study Management
Case Study: Reduce Costs, Expedite Outcomes with EnsoSleep PPG
In just 3 months, Chicago ENT/Chicago Sleep Center (CENT/CSC) transitioned more than 75% of their home sleep testing volume from flow-based devices to PPG-based devices, corresponding to a 92.5% reduction in cost per new HSAT device.
Access the Case Study to Explore CENT/CSC’s Rapid and Efficient EnsoSleep PPG Adoption.
"We went from a $2,000 piece of hardware to a $150 piece of hardware, with no disposables. Those economics make EnsoSleep PPG very attractive." Scott Rice, Director of Ancillary Services
Celeste+ is a mobile app (Android and iOS) used to seamlessly collect and transfer data from pulse oximeters to EnsoSleep PPG.
EnsoSleep PPG Clinical Performance
These key metrics demonstrate the clinical impact of EnsoSleep PPG
Multi-Night Testing Addresses Inter-Night Variability
Relying on a single night of testing can lead to missed diagnoses in more than 1 in 10 patients.1 More than 1 in 4 patients1 may experience a jump in OSA severity by at least one category on subsequent nights. This can prevent patients from receiving the diagnosis and treatment they need to improve their overall health.
“The high rate of missed diagnosis due to single-night testing gives the sleep medicine community the opportunity to reexamine current testing methods and explore the benefits of multi-night testing. In terms of clinical effectiveness and the future of sleep medicine diagnostics, it may well be more productive to monitor one polysomnographic component for 20 nights rather than monitoring 20 components for one night.”
Nathaniel F. Watson, MD, MSc, Chief Medical Officer, EnsoData, AASM Past-President
Remote Physiological Monitoring
Optimize patient outcomes with efficient, accurate RPM
Seamlessly monitor patient success on OSA therapies such as CPAP, implantable devices, oral appliances, and GLP-1s with long-term nightly measurement of AHI.
EnsoData’s™ remote physiological monitoring (RPM) solution provides clinicians with valuable insights into a patient’s therapy success–gathered from the comfort and convenience of the patient’s home using affordable, easy-to-use PPG devices.
Schedule a Demo
Explore EnsoSleep PPG for affordable, multi-night HSAT
Complete our form and we’ll reach out to schedule a demo and answer your questions about EnsoSleep PPG.
We’d love to help you reach more patients and accelerate the identification, diagnosis, and treatment of sleep-disordered breathing with accurate, affordable, accessible multi-night home sleep testing using pulse ox devices.
To learn more, read our blog about the what, how, and why behind EnsoSleep PPG.
Simplify and accelerate the sleep testing, diagnosis and treatment workflow for sleep clinicians and sleep labs with one cloud-based solution for sleep study viewing, editing, and reporting.
EnsoSleep FDA-cleared AI-assisted sleep scoring and analysis solution automates the scoring of studies, and reduces the time RPSGTs spend scoring PSGs and HSATs. Consistent, reliable results provide clinicians with more time to expand patient care, improve outcomes and treat more patients.
EnsoSleep produces an accurate Total Sleep Time (TST) for HSAT devices that do not calculate a measurement of sleep time. Including TST results in improved diagnostic accuracy for clinicians and patients and potential increased reimbursement.
